secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2021-10-20T23:59:59+00:00
Accession:  0001193125-21-303045
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics files amended charter post-IPO, authorizing 150M common and 5M preferred shares
--------------------------------------------------------------------------------

- Amended charter and bylaws became effective upon IPO closing on October 19, 2021.
- Authorized capital: 150,000,000 shares of common stock, par value $0.00001 per share.
- Authorized capital includes 5,000,000 shares of preferred stock.
- Charter and bylaws are in the form previously filed with the Registration Statement on Form S-1.
- No other material modifications to security holder rights were reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/0001193125-21-303045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/d134002d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-303045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer